Monday, October 5, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· April 26, 2026

Why the Housing Market Is Stalling — Sales Fall 3.6% As Mortgage Rates Climb And Forecasts Get Cut

View original at finance.yahoo.com
“The median existing home sales price rose to $408,800, a 1.4% increase for March 2025.”
Verbatim excerpt from the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The two-speed nature of the housing market is becoming more pronounced, with high-cost coastal and Sun Belt regions undergoing price corrections while the Midwest and Northeast remain resilient.

    60% confidence
  • High-cost coastal and Sun Belt regions are undergoing price corrections because of affordability reasons, while the Midwest and Northeast have remained resilient because of their affordability and stable employment bases.

    60% confidence
  • The typical homeowner has accumulated $128,100 in housing wealth over the last six years.

    60% confidence
  • Sluggish consumer confidence and a tightening mortgage environment are the primary culprits for the decline in existing home sales.

    60% confidence
  • Many house hunters are sidelined not just by rates but by a stalled labor market and economic uncertainty.

    60% confidence
  • Many house hunters are sidelined not just by rates but by a stalled labor market and economic uncertainty.

    60% confidence
  • March 2025 marked the 33rd consecutive month of year-over-year existing home price gains.

    60% confidence
  • Locations with consistent job growth will remain the primary engines for price appreciation, but they also have larger inventory deficits which are driving pressure on home prices.

    60% confidence
  • An additional 300,000 to 500,000 homes for sale would help bring the market closer to normal conditions and allow consumers to make purchase decisions without feeling rushed.

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,340 source documents archived
Query this data → isubstrate.com